SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.
Adult
Aged
Aged, 80 and over
Basic Reproduction Number
Betacoronavirus
COVID-19
COVID-19 Vaccines
Congresses as Topic
Coronavirus Infections
/ epidemiology
Drug Design
Female
Global Health
Humans
International Cooperation
Internet
Male
Middle Aged
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Reference Standards
SARS-CoV-2
Seasons
Telecommunications
Viral Vaccines
Virology
/ trends
Young Adult
Epidemiology
Immunology
SARS-CoV-2
Vaccine development
Virology
Journal
Biologicals : journal of the International Association of Biological Standardization
ISSN: 1095-8320
Titre abrégé: Biologicals
Pays: England
ID NLM: 9004494
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
17
06
2020
accepted:
19
06
2020
pubmed:
1
7
2020
medline:
7
8
2020
entrez:
1
7
2020
Statut:
ppublish
Résumé
This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.
Identifiants
pubmed: 32600951
pii: S1045-1056(20)30066-X
doi: 10.1016/j.biologicals.2020.06.005
pmc: PMC7309765
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35-40Informations de copyright
Copyright © 2020. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no competing interests to declare.
Références
J Clin Med. 2020 Jun 16;9(6):
pubmed: 32560044
JAMA. 2020 Jun 9;323(22):2340-2341
pubmed: 32401274
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
J Gen Virol. 2020 Aug;101(8):791-797
pubmed: 32430094
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
J Infect Dis. 2008 Jan 15;197(2):270-8
pubmed: 18194088
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13422-7
pubmed: 23882078
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Vaccine. 2021 Jan 22;39(4):633-640
pubmed: 33341309
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Biologicals. 2019 Sep;61:85-94
pubmed: 29573967
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Infect Dis. 2020 Jun 16;222(1):9-16
pubmed: 32246136
PLoS One. 2014 Jul 29;9(7):e102429
pubmed: 25072598
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2
pubmed: 32360285